Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mott David M
Relationship:   Director
City:   Gaithersburg
State:   MD
   
Insider Summary:
  
   
Companies Owned :   36    
Direct Shares   6,113,369    

Indirect Shares

   266,283,930      
Direct Value   $9,400,912    

Indirect Value

   $992,446,633      
Total Shares   272,397,299      
Total Value   $1,001,847,545      


Ardelyx Inc $7,654,406 Mersana Therapeutics, Inc. $1,730,760 Cloudflare, Inc. $0 Novavax Inc $15,746 Enliven Therapeutics Ord Shs $0 Ardelyx Inc $7,654,406 Mersana Therapeutics, Inc. $1,730,760 Cloudflare, Inc. $0 Novavax Inc $15,746 Enliven Therapeutics Ord Shs $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    0    

     Stock price went up :
    4   
    0    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   23.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Medimmune Inc MEDI Vice Chairman, CEO & P... 2007-06-01 0 2003-09-15 0    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2013-06-03 575    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO Director, 10% Owner 2019-01-22 0 2019-01-22 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-09 0 2013-04-09 1,171    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM Director 2022-08-12 0 2022-08-12 0    Premium*  
            Care.com Inc CRCM 10% Owner 2014-01-29 0 2017-11-06 2,302    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX Director 2023-06-15 1,192,275 2019-12-09 6,564,372    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director, 10% Owner 0 2020-01-24 102,478,668    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2019-04-08 25,243,865    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN Director 2024-01-02 588,694 2024-01-02 9,595    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2019-05-07 2,052,454    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2017-11-20 0 2018-02-13 2,031    Premium*  
            Elastic N.v. ESTC 10% Owner 2018-10-10 0 2018-10-10 2,197,503    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2019-06-24 7,225,676    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2019-05-09 4,438,562    Premium*  
            Nightstar Therapeutics Plc NITE Director, 10% Owner 2019-06-07 0 2019-06-07 0    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2019-07-22 4,186,243    Premium*  
            Cloudflare, Inc. NET 10% Owner 2019-09-17 4,059,376 2019-09-17 0    Premium*  
            Novavax Inc NVAX Director 2023-06-10 43,800 0    Premium*  
            Enliven Therapeutics Ord Shs ELVN Director 2022-02-23 229,224 2022-02-10 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2024-01-02 4 A $0.00 $0 D/D 8,810 588,694 0 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2023-10-02 4 A $0.00 $0 D/D 15,873 579,884 0 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2023-07-03 4 A $0.00 $0 D/D 6,079 564,011 0 -
ARDX Ardelyx Inc Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 25,510 1,192,275 0 -
NVAX Novavax Inc Director   –       •      –    2023-06-10 4 OE $0.00 $0 D/D 3,100 43,800 0 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2023-06-08 4 A $0.00 $0 D/D 14,467 557,932 0 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2023-04-03 4 A $0.00 $0 D/D 4,866 543,465 0 -
ARDX Ardelyx Inc Director   –       •      –    2022-11-17 4 B $1.76 $1,000,642 D/D 567,000 1,166,765 2.39 %
EPZM Epizyme, Inc. Director   –       •      –    2022-08-12 4 D $0.00 $0 I/I (106,959) 0 0 -
EPZM Epizyme, Inc. Director   –       •      –    2022-08-12 4 D $0.00 $0 D/D (8,994) 0 0 -
EPZM Epizyme, Inc. Director   –       •      –    2022-08-12 4 D $0.00 $0 D/D (215,494) 8,994 0 -
EPZM Epizyme, Inc. Director   –       •      –    2022-06-30 4 A $1.47 $23,749 D/D 16,156 224,488 0 -
NVAX Novavax Inc Director   –       •      –    2022-06-17 4 OE $0.00 $0 D/D 700 40,700 0 -
ARDX Ardelyx Inc Director   –       •      –    2022-06-15 4 A $0.00 $0 D/D 182,481 599,765 0 -
EPZM Epizyme, Inc. Director   –       •      –    2022-05-17 4 A $0.00 $0 D/D 8,994 208,332 0 -
EPZM Epizyme, Inc. Director   –       •      –    2022-03-31 4 A $1.15 $23,751 D/D 20,653 199,338 0 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-23 4 B $1.46 $51,475 D/D 35,257 229,224 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-22 4 B $1.56 $102,675 D/D 65,817 193,967 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-18 4 B $1.30 $65,517 D/D 50,398 128,150 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-17 4 B $1.17 $17,076 D/D 14,595 77,752 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-16 4 B $1.20 $14,135 D/D 11,779 63,157 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-15 4 B $1.20 $23,462 D/D 19,552 51,378 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-14 4 B $1.18 $10,030 D/D 8,500 31,826 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-11 4 B $1.23 $17,925 D/D 14,573 23,326 2.39 -
ELVN Enliven Therapeutics Ord ... Director   –       •      –    2022-02-10 4 B $1.29 $11,291 D/D 8,753 8,753 2.39 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us